|
|
|
Insider
Information: |
Johnson & Johnson Development Corp Et Al |
Relationship: |
10% Owner |
City: |
New Brunswick |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
10,136,639 |
|
Indirect Shares
|
43,524,732 |
|
|
Direct
Value |
$65,270,298 |
|
|
Indirect Value
|
$357,828,956 |
|
|
Total
Shares |
53,661,371 |
|
|
Total
Value |
$423,099,254 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-31.6%
|
-58.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Immunicon Corp |
IMMCQ |
10% Owner |
|
0 |
2004-06-10 |
1,771,571 |
Premium* |
|
Universal Biosensors Inc |
UVBIF |
10% Owner |
|
0 |
2011-09-08 |
15,749,937 |
Premium* |
|
Tengion Inc |
TNGN |
10% Owner |
2010-04-14 |
0 |
2010-04-14 |
1,194,654 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2014-02-10 |
0 |
2014-03-12 |
1,392,094 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2014-03-12 |
0 |
2015-08-11 |
100,000 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-01 |
0 |
2014-05-01 |
1,750,292 |
Premium* |
|
Minerva Neurosciences, Inc. |
NERV |
10% Owner |
|
0 |
2017-08-29 |
0 |
Premium* |
|
Nevro Corp |
NVRO |
10% Owner |
2014-11-12 |
0 |
2015-06-08 |
2,066,740 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2017-11-20 |
0 |
Premium* |
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
2016-08-16 |
0 |
2016-08-16 |
2,449,183 |
Premium* |
|
Inspire Medical Systems Inc |
INSP |
10% Owner |
2018-05-07 |
0 |
2018-05-07 |
235,251 |
Premium* |
|
Provention Bio Inc |
PRVB |
10% Owner |
2018-07-19 |
0 |
2018-07-19 |
2,400,000 |
Premium* |
|
Fusion Pharmaceuticals Inc. |
FUSN |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
3,670,516 |
Premium* |
|
Cvrx, Inc. |
CVRX |
|
2023-09-15 |
3,495,575 |
2024-02-29 |
4,103,430 |
Premium* |
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2023-09-15 |
6,641,064 |
2022-11-09 |
6,641,064 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-14 |
5 |
S |
$1.41 |
$14,100 |
I/I |
(10,000) |
17,341,530 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-15 |
5 |
S |
$1.42 |
$10,650 |
I/I |
(7,500) |
17,334,030 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-18 |
5 |
S |
$1.42 |
$11,360 |
I/I |
(8,000) |
17,326,030 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-20 |
5 |
S |
$1.44 |
$14,400 |
I/I |
(10,000) |
17,316,030 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-21 |
5 |
S |
$1.49 |
$52,150 |
I/I |
(35,000) |
17,281,030 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-27 |
5 |
S |
$1.51 |
$15,100 |
I/I |
(10,000) |
17,271,030 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-28 |
5 |
S |
$1.52 |
$15,200 |
I/I |
(10,000) |
17,261,030 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-04-29 |
5 |
S |
$1.53 |
$15,300 |
I/I |
(10,000) |
17,251,030 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-07-28 |
5 |
S |
$1.30 |
$443 |
I/I |
(341) |
17,250,689 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-08-01 |
5 |
S |
$1.19 |
$895 |
I/I |
(752) |
17,249,937 |
0 |
- |
|
UVBIF |
Universal Biosensors Inc |
10% Owner |
|
2011-09-08 |
5 |
S |
$0.96 |
$1,440,000 |
I/I |
(1,500,000) |
15,749,937 |
0 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
I/I |
1,388,645 |
1,388,645 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-03-12 |
4/A |
B |
$11.00 |
$2,999,997 |
I/I |
272,727 |
1,664,821 |
1.5 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-03-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,392,094 |
1,392,094 |
0 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2014-03-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,392,094 |
1,392,094 |
0 |
- |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2014-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,724,478 |
1,724,478 |
0 |
- |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2014-05-01 |
4 |
OE |
$5.16 |
$375,080 |
I/I |
72,690 |
1,773,730 |
0 |
- |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2014-05-01 |
4 |
D |
$8.00 |
$375,008 |
I/I |
(46,876) |
1,750,292 |
0 |
- |
|
NERV |
Minerva Neurosciences, In... |
10% Owner |
|
2014-07-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,284,353 |
|
- |
|
NVRO |
Nevro Corp |
10% Owner |
|
2014-11-12 |
4 |
B |
$18.00 |
$720,000 |
I/I |
40,000 |
3,077,005 |
1.5 |
- |
|
NVRO |
Nevro Corp |
10% Owner |
|
2014-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,037,005 |
3,037,005 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-11-20 |
4 |
S |
$8.21 |
$25,451 |
I/I |
(3,100) |
1,388,994 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-11-21 |
4 |
S |
$8.25 |
$19,800 |
I/I |
(2,400) |
1,386,594 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-11-24 |
4 |
S |
$8.02 |
$32,080 |
I/I |
(4,000) |
1,382,594 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-11-25 |
4 |
S |
$7.80 |
$11,700 |
I/I |
(1,500) |
1,381,094 |
0 |
- |
|
111 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|